Despite strong growth in the overall biopharmaceutical market and the biopharma contract services market, manufacturers of biologic APIs and drug products face innumerable challenges, from increasing cost pressures to ... read more

While the pharmaceutical contract services market is growing at a healthy rate, CROs and CDMOs are competing head-to-head to earn the right to be preferred providers, while other contract and specialty service providers are ... read more